Featured Priority: Vaccine Innovation
Vaccine innovation – including the development of new and improved vaccines – is critical to improving public health and tackling emerging disease threats. We work with federal and non-federal partners to encourage vaccine innovation in several ways.
Modernizing Flu Vaccines
In September 2019, the Administration issued an Executive Order on modernizing influenza vaccines in the United States to promote national security and public health.
21st Century Cures Report on Encouraging Vaccine Innovation
The 21st Century Cures Act, signed into law in 2016, intends to accelerate the process of discovery, development, and delivery of health care innovation. A provision of the Act directs HHS to submit a report to Congress on encouraging vaccine innovation. The final report examines the current state of U.S. vaccine development and innovation, highlights existing challenges, and offers potential opportunities and levers that have the potential to shift the balance of decision-making to favor innovation.
Read the report: Encouraging Vaccine Innovation: Promoting the Development of Vaccines that Minimize the Burden of Infectious Diseases in the 21st Century
National Vaccine Plan
Developing new and improved vaccines is one of five goals outlined in the National Vaccine Plan. This goal calls for improved understanding of new vaccine targets as well as support for upstream research and innovations in vaccine development and delivery. Read more about this goal.
As a step toward this goal, we partnered to develop the SMART Vaccine Tool.
National Adult Immunization Plan
Goal 4 of the National Adult Immunization Plan (NAIP) aims to foster innovation in adult vaccine development and vaccine-related technologies. It encourages the development of new, more effective vaccines for adults and technological advancements in improving vaccine delivery. Read more about this goal.
